TransCode Therapeutics Inc (NASDAQ:RNAZ) Has Already Recovered 6.41%, But Another -6807.87% Drop Cannot Be Ruled Out.
In last trading session, TransCode Therapeutics Inc (NASDAQ:RNAZ) saw 95599.0 shares changing hands with its beta currently measuring 0.75. Company’s recent per share price level